Table of Contents Chapter 1 Overview of Neuromodulation Devices and Implantable Infusion Pumps 1.1 Definition of Neuromodulation Devices and Implantable Infusion Pumps in This Report 1.2 Commercial Types of Neuromodulation Devices and Implantable Infusion Pumps 1.2.1 Neuromodulation Devices 1.2.2 Implantable Infusion Pumps 1.3 Downstream Application of Neuromodulation Devices and Implantable Infusion Pumps 1.3.1 Clinic 1.3.2 Hospital 1.4 Development History of Neuromodulation Devices and Implantable Infusion Pumps 1.5 Market Status and Trend of Neuromodulation Devices and Implantable Infusion Pumps 2013-2023 1.5.1 United States Neuromodulation Devices and Implantable Infusion Pumps Market Status and Trend 2013-2023 1.5.2 Regional Neuromodulation Devices and Implantable Infusion Pumps Market Status and Trend 2013-2023 Chapter 2 United States Market Status and Forecast by Regions 2.1 Market Status of Neuromodulation Devices and Implantable Infusion Pumps in United States 2013-2017 2.2 Consumption Market of Neuromodulation Devices and Implantable Infusion Pumps in United States by Regions 2.2.1 Consumption Volume of Neuromodulation Devices and Implantable Infusion Pumps in United States by Regions 2.2.2 Revenue of Neuromodulation Devices and Implantable Infusion Pumps in United States by Regions 2.3 Market Analysis of Neuromodulation Devices and Implantable Infusion Pumps in United States by Regions 2.3.1 Market Analysis of Neuromodulation Devices and Implantable Infusion Pumps in New England 2013-2017 2.3.2 Market Analysis of Neuromodulation Devices and Implantable Infusion Pumps in The Middle Atlantic 2013-2017 2.3.3 Market Analysis of Neuromodulation Devices and Implantable Infusion Pumps in The Midwest 2013-2017 2.3.4 Market Analysis of Neuromodulation Devices and Implantable Infusion Pumps in The West 2013-2017 2.3.5 Market Analysis of Neuromodulation Devices and Implantable Infusion Pumps in The South 2013-2017 2.3.6 Market Analysis of Neuromodulation Devices and Implantable Infusion Pumps in Southwest 2013-2017 2.4 Market Development Forecast of Neuromodulation Devices and Implantable Infusion Pumps in United States 2018-2023 2.4.1 Market Development Forecast of Neuromodulation Devices and Implantable Infusion Pumps in United States 2018-2023 2.4.2 Market Development Forecast of Neuromodulation Devices and Implantable Infusion Pumps by Regions 2018-2023 Chapter 3 United States Market Status and Forecast by Types 3.1 Whole United States Market Status by Types 3.1.1 Consumption Volume of Neuromodulation Devices and Implantable Infusion Pumps in United States by Types 3.1.2 Revenue of Neuromodulation Devices and Implantable Infusion Pumps in United States by Types 3.2 United States Market Status by Types in Major Countries 3.2.1 Market Status by Types in New England 3.2.2 Market Status by Types in The Middle Atlantic 3.2.3 Market Status by Types in The Midwest 3.2.4 Market Status by Types in The West 3.2.5 Market Status by Types in The South 3.2.6 Market Status by Types in Southwest 3.3 Market Forecast of Neuromodulation Devices and Implantable Infusion Pumps in United States by Types Chapter 4 United States Market Status and Forecast by Downstream Industry 4.1 Demand Volume of Neuromodulation Devices and Implantable Infusion Pumps in United States by Downstream Industry 4.2 Demand Volume of Neuromodulation Devices and Implantable Infusion Pumps by Downstream Industry in Major Countries 4.2.1 Demand Volume of Neuromodulation Devices and Implantable Infusion Pumps by Downstream Industry in New England 4.2.2 Demand Volume of Neuromodulation Devices and Implantable Infusion Pumps by Downstream Industry in The Middle Atlantic 4.2.3 Demand Volume of Neuromodulation Devices and Implantable Infusion Pumps by Downstream Industry in The Midwest 4.2.4 Demand Volume of Neuromodulation Devices and Implantable Infusion Pumps by Downstream Industry in The West 4.2.5 Demand Volume of Neuromodulation Devices and Implantable Infusion Pumps by Downstream Industry in The South 4.2.6 Demand Volume of Neuromodulation Devices and Implantable Infusion Pumps by Downstream Industry in Southwest 4.3 Market Forecast of Neuromodulation Devices and Implantable Infusion Pumps in United States by Downstream Industry Chapter 5 Market Driving Factor Analysis of Neuromodulation Devices and Implantable Infusion Pumps 5.1 United States Economy Situation and Trend Overview 5.2 Neuromodulation Devices and Implantable Infusion Pumps Downstream Industry Situation and Trend Overview Chapter 6 Neuromodulation Devices and Implantable Infusion Pumps Market Competition Status by Major Players in United States 6.1 Sales Volume of Neuromodulation Devices and Implantable Infusion Pumps in United States by Major Players 6.2 Revenue of Neuromodulation Devices and Implantable Infusion Pumps in United States by Major Players 6.3 Basic Information of Neuromodulation Devices and Implantable Infusion Pumps by Major Players 6.3.1 Headquarters Location and Established Time of Neuromodulation Devices and Implantable Infusion Pumps Major Players 6.3.2 Employees and Revenue Level of Neuromodulation Devices and Implantable Infusion Pumps Major Players 6.4 Market Competition News and Trend 6.4.1 Merger, Consolidation or Acquisition News 6.4.2 Investment or Disinvestment News 6.4.3 New Product Development and Launch Chapter 7 Neuromodulation Devices and Implantable Infusion Pumps Major Manufacturers Introduction and Market Data 7.1 Advanced Bionics/Sonova 7.1.1 Company profile 7.1.2 Representative Neuromodulation Devices and Implantable Infusion Pumps Product 7.1.3 Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin of Advanced Bionics/Sonova 7.2 Cerbomed 7.2.1 Company profile 7.2.2 Representative Neuromodulation Devices and Implantable Infusion Pumps Product 7.2.3 Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin of Cerbomed 7.3 Cochlear 7.3.1 Company profile 7.3.2 Representative Neuromodulation Devices and Implantable Infusion Pumps Product 7.3.3 Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin of Cochlear 7.4 ImThera 7.4.1 Company profile 7.4.2 Representative Neuromodulation Devices and Implantable Infusion Pumps Product 7.4.3 Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin of ImThera 7.5 MED-EL 7.5.1 Company profile 7.5.2 Representative Neuromodulation Devices and Implantable Infusion Pumps Product 7.5.3 Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin of MED-EL 7.6 Neurelec 7.6.1 Company profile 7.6.2 Representative Neuromodulation Devices and Implantable Infusion Pumps Product 7.6.3 Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin of Neurelec 7.7 Boston Scientific 7.7.1 Company profile 7.7.2 Representative Neuromodulation Devices and Implantable Infusion Pumps Product 7.7.3 Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin of Boston Scientific 7.8 CerebralRx 7.8.1 Company profile 7.8.2 Representative Neuromodulation Devices and Implantable Infusion Pumps Product 7.8.3 Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin of CerebralRx 7.9 Codman & Shurtleff (Johnson & Johnson) 7.9.1 Company profile 7.9.2 Representative Neuromodulation Devices and Implantable Infusion Pumps Product 7.9.3 Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin of Codman & Shurtleff (Johnson & Johnson) 7.10 Flowonix 7.10.1 Company profile 7.10.2 Representative Neuromodulation Devices and Implantable Infusion Pumps Product 7.10.3 Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin of Flowonix 7.11 Inspire Medical Systems 7.11.1 Company profile 7.11.2 Representative Neuromodulation Devices and Implantable Infusion Pumps Product 7.11.3 Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin of Inspire Medical Systems 7.12 LivaNova (formerly Cyberonics) 7.12.1 Company profile 7.12.2 Representative Neuromodulation Devices and Implantable Infusion Pumps Product 7.12.3 Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin of LivaNova (formerly Cyberonics) 7.13 Medtronic 7.13.1 Company profile 7.13.2 Representative Neuromodulation Devices and Implantable Infusion Pumps Product 7.13.3 Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin of Medtronic 7.14 Neuronetics 7.14.1 Company profile 7.14.2 Representative Neuromodulation Devices and Implantable Infusion Pumps Product 7.14.3 Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin of Neuronetics 7.15 NeuroPace 7.15.1 Company profile 7.15.2 Representative Neuromodulation Devices and Implantable Infusion Pumps Product 7.15.3 Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin of NeuroPace 7.16 NeuroSigma 7.17 Nurotron 7.18 St. Jude Medical Chapter 8 Upstream and Downstream Market Analysis of Neuromodulation Devices and Implantable Infusion Pumps 8.1 Industry Chain of Neuromodulation Devices and Implantable Infusion Pumps 8.2 Upstream Market and Representative Companies Analysis 8.3 Downstream Market and Representative Companies Analysis Chapter 9 Cost and Gross Margin Analysis of Neuromodulation Devices and Implantable Infusion Pumps 9.1 Cost Structure Analysis of Neuromodulation Devices and Implantable Infusion Pumps 9.2 Raw Materials Cost Analysis of Neuromodulation Devices and Implantable Infusion Pumps 9.3 Labor Cost Analysis of Neuromodulation Devices and Implantable Infusion Pumps 9.4 Manufacturing Expenses Analysis of Neuromodulation Devices and Implantable Infusion Pumps Chapter 10 Marketing Status Analysis of Neuromodulation Devices and Implantable Infusion Pumps 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List Chapter 11 Report Conclusion Chapter 12 Research Methodology and Reference 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Reference

List of Tables Table Advantage and Disadvantage of Neuromodulation Devices Table Advantage and Disadvantage of Implantable Infusion Pumps Table Consumption Volume of Neuromodulation Devices and Implantable Infusion Pumps in United States by Regions 2013-2017 Table Revenue of Neuromodulation Devices and Implantable Infusion Pumps in United States by Regions 2013-2017 Table Consumption Volume of Neuromodulation Devices and Implantable Infusion Pumps in United States by Regions 2018-2023 Table Revenue of Neuromodulation Devices and Implantable Infusion Pumps in United States by Regions 2018-2023 Table Consumption Volume of Neuromodulation Devices and Implantable Infusion Pumps in United States by Types 2013-2017 Table Revenue of Neuromodulation Devices and Implantable Infusion Pumps in United States by Types 2013-2017 Table Consumption Volume of Neuromodulation Devices and Implantable Infusion Pumps by Types in New England 2013-2017 Table Consumption Volume of Neuromodulation Devices and Implantable Infusion Pumps by Types in The Middle Atlantic 2013-2017 Table Consumption Volume of Neuromodulation Devices and Implantable Infusion Pumps by Types in The Midwest 2013-2017 Table Consumption Volume of Neuromodulation Devices and Implantable Infusion Pumps by Types in The West 2013-2017 Table Consumption Volume of Neuromodulation Devices and Implantable Infusion Pumps by Types in The South 2013-2017 Table Consumption Volume of Neuromodulation Devices and Implantable Infusion Pumps by Types in Southwest 2013-2017 Table Consumption Volume Forecast of Neuromodulation Devices and Implantable Infusion Pumps in United States by Types 2018-2023 Table Revenue Forecast of Neuromodulation Devices and Implantable Infusion Pumps in United States by Types 2018-2023 Table Demand Volume of Neuromodulation Devices and Implantable Infusion Pumps in United States by Downstream Industry 2013-2017 Table Demand Volume of Neuromodulation Devices and Implantable Infusion Pumps by Downstream Industry in New England 2013-2017 Table Demand Volume of Neuromodulation Devices and Implantable Infusion Pumps by Downstream Industry in The Middle Atlantic 2013-2017 Table Demand Volume of Neuromodulation Devices and Implantable Infusion Pumps by Downstream Industry in The Midwest 2013-2017 Table Demand Volume of Neuromodulation Devices and Implantable Infusion Pumps by Downstream Industry in The West 2013-2017 Table Demand Volume of Neuromodulation Devices and Implantable Infusion Pumps by Downstream Industry in The South 2013-2017 Table Demand Volume of Neuromodulation Devices and Implantable Infusion Pumps by Downstream Industry in Southwest 2013-2017 Table Demand Volume Forecast of Neuromodulation Devices and Implantable Infusion Pumps in United States by Downstream Industry 2018-2023 Table Sales Volume of Neuromodulation Devices and Implantable Infusion Pumps in United States by Major Players 2013-2017 Table Revenue of Neuromodulation Devices and Implantable Infusion Pumps in United States by Major Players 2013-2017 Table Headquarters Location and Established Time of Neuromodulation Devices and Implantable Infusion Pumps Major Players Table Employees and Revenue Level of Neuromodulation Devices and Implantable Infusion Pumps Major Players Table Representative Neuromodulation Devices and Implantable Infusion Pumps Product One of Advanced Bionics/Sonova Table Representative Neuromodulation Devices and Implantable Infusion Pumps Product Two of Advanced Bionics/Sonova Table Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin of Advanced Bionics/Sonova 2013-2017 Table Representative Neuromodulation Devices and Implantable Infusion Pumps Product One of Cerbomed Table Representative Neuromodulation Devices and Implantable Infusion Pumps Product Two of Cerbomed Table Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin of Cerbomed 2013-2017 Table Representative Neuromodulation Devices and Implantable Infusion Pumps Product One of Cochlear Table Representative Neuromodulation Devices and Implantable Infusion Pumps Product Two of Cochlear Table Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin of Cochlear 2013-2017 Table Representative Neuromodulation Devices and Implantable Infusion Pumps Product One of ImThera Table Representative Neuromodulation Devices and Implantable Infusion Pumps Product Two of ImThera Table Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin of ImThera 2013-2017 Table Representative Neuromodulation Devices and Implantable Infusion Pumps Product One of MED-EL Table Representative Neuromodulation Devices and Implantable Infusion Pumps Product Two of MED-EL Table Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin of MED-EL 2013-2017 Table Representative Neuromodulation Devices and Implantable Infusion Pumps Product One of Neurelec Table Representative Neuromodulation Devices and Implantable Infusion Pumps Product Two of Neurelec Table Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin of Neurelec 2013-2017 Table Representative Neuromodulation Devices and Implantable Infusion Pumps Product One of Boston Scientific Table Representative Neuromodulation Devices and Implantable Infusion Pumps Product Two of Boston Scientific Table Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin of Boston Scientific 2013-2017 Table Representative Neuromodulation Devices and Implantable Infusion Pumps Product One of CerebralRx Table Representative Neuromodulation Devices and Implantable Infusion Pumps Product Two of CerebralRx Table Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin of CerebralRx 2013-2017 Table Representative Neuromodulation Devices and Implantable Infusion Pumps Product One of Codman & Shurtleff (Johnson & Johnson) Table Representative Neuromodulation Devices and Implantable Infusion Pumps Product Two of Codman & Shurtleff (Johnson & Johnson) Table Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin of Codman & Shurtleff (Johnson & Johnson) 2013-2017 Table Representative Neuromodulation Devices and Implantable Infusion Pumps Product One of Flowonix Table Representative Neuromodulation Devices and Implantable Infusion Pumps Product Two of Flowonix Table Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin of Flowonix 2013-2017 Table Representative Neuromodulation Devices and Implantable Infusion Pumps Product One of Inspire Medical Systems Table Representative Neuromodulation Devices and Implantable Infusion Pumps Product Two of Inspire Medical Systems Table Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin of Inspire Medical Systems 2013-2017 Table Representative Neuromodulation Devices and Implantable Infusion Pumps Product One of LivaNova (formerly Cyberonics) Table Representative Neuromodulation Devices and Implantable Infusion Pumps Product Two of LivaNova (formerly Cyberonics) Table Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin of LivaNova (formerly Cyberonics) 2013-2017 Table Representative Neuromodulation Devices and Implantable Infusion Pumps Product One of Medtronic Table Representative Neuromodulation Devices and Implantable Infusion Pumps Product Two of Medtronic Table Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin of Medtronic 2013-2017 Table Representative Neuromodulation Devices and Implantable Infusion Pumps Product One of Neuronetics Table Representative Neuromodulation Devices and Implantable Infusion Pumps Product Two of Neuronetics Table Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin of Neuronetics 2013-2017 Table Representative Neuromodulation Devices and Implantable Infusion Pumps Product One of NeuroPace Table Representative Neuromodulation Devices and Implantable Infusion Pumps Product Two of NeuroPace Table Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin of NeuroPace 2013-2017